Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Vitura Health.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: What’s up, Doc? Not much – post Covid patients are still avoiding GP visits
Health & Biotech
Health Check: Vitura Health swoops on medical dope telehealth platform
Health & Biotech
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
Health & Biotech
Alive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raise
Health & Biotech
ASX wellness stocks offering calm and anxiety relief – Part 2
Health & Biotech
Weed Week: It’s showtime! Cannabis could come back from the dead as US makes biggest move in 50 years
Health & Biotech
Weed Week: A VAST majority of Americans now want marijuana to be legal
Health & Biotech
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
Health & Biotech
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
News
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
News
Closing Bell: Stocks putting out good news, sneaking in bad news while almost everyone watches the cricket
Health & Biotech
Weed Week: Jamaican nettletree could be a new, cheaper option to source CBD, says scientists
Health & Biotech
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
News
